Publication | Open Access
TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
34
Citations
19
References
2021
Year
Our study revealed that TTK may be a promising therapeutic target for cisplatin-resistant ovarian cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1